HIGHLIGHTS
- who: Tomoharu Sugie from the University of Milan, Italy have published the research: Editorial: Advancements in immunology and immunotherapy for breast cancer, in the Journal: (JOURNAL)
- how: Accumulated results indicated that the presence of B cells and tertiary lymphoid structure (TLS) in tumors were associated with a favorable outcome in patients treated with immunotherapy and this relationship between humoral and cell-mediated immunity gradually became clear . These results indicated that both C5rAR2 and GOLT1B were a potential negative predictive biomarker in relation to pro-tumor immunity.
- future: Study is required to elucidate the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.